Loading…

Haptic Evaluation of 3D-printed Braille-encoded Intraoral Films

The three-dimensional (3D) printing technology has recently emerged in the pharmaceutical field, providing an array of applications for individualized dosing and elaborate formulation designs. However, an alternative asset of the 3D printing technology is the capability to imprint haptic identifiers...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pharmaceutical sciences 2021-02, Vol.157, p.105605-105605, Article 105605
Main Authors: Eleftheriadis, Georgios K., Fatouros, Dimitrios G.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-6a26c0f7fa3b62c1da3ac80f8a135c45440716c58031693a8c62550ddff44a113
cites cdi_FETCH-LOGICAL-c356t-6a26c0f7fa3b62c1da3ac80f8a135c45440716c58031693a8c62550ddff44a113
container_end_page 105605
container_issue
container_start_page 105605
container_title European journal of pharmaceutical sciences
container_volume 157
creator Eleftheriadis, Georgios K.
Fatouros, Dimitrios G.
description The three-dimensional (3D) printing technology has recently emerged in the pharmaceutical field, providing an array of applications for individualized dosing and elaborate formulation designs. However, an alternative asset of the 3D printing technology is the capability to imprint haptic identifiers directly onto the surface of the formulations. This approach can generate novel design concepts, that will serve specific populations for identifying the right treatment regimen, i.e., visually impaired people. Toward this direction, the fused deposition modelling (FDM) technique was investigated for manufacturing intraoral films and incorporating Braille characters on the available area. The films comprised a drug-loaded compartment and a backing layer, which are typical structural characteristics for buccal delivery. A hydrophilic polymer, i.e., hydroxypropyl methylcellulose, provided the polymer matrix for both compartments, whereas ketoprofen was incorporated in the study as model drug. The Braille-encoded texts were designed on top of the backing layer, complying with the Marburg Medium spacing convention for pharmaceutical Braille. Moreover, modifications on the standard spacing and dimension parameters were applied, to investigate the accuracy and repeatability of the FDM process. The fabricated films were subjected to a haptic evaluation study with the aid of visually impaired individuals, to assess the readability of the 3D-printed Braille-encoded text. The outcomes of the study highlighted the capacity of the FDM technology in combining novel manufacturing concepts for individualized therapies with customized services that can be provided to specific populations, as in the case of people with visual impairment. [Display omitted]
doi_str_mv 10.1016/j.ejps.2020.105605
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2454156767</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0928098720303936</els_id><sourcerecordid>2454156767</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-6a26c0f7fa3b62c1da3ac80f8a135c45440716c58031693a8c62550ddff44a113</originalsourceid><addsrcrecordid>eNp9kEFLwzAUx4Mobk6_gAfp0UvnS9IkLQiic3ODgRc9hyxNIaVtatIO_Pa2dHr09HiP3_8P74fQLYYlBswfyqUp27AkQMYD48DO0BynIotBEDhHc8hIGkOWihm6CqEEAJ4KuEQzSiHDTMAcPW1V21kdrY-q6lVnXRO5IqKvcett05k8evHKVpWJTaNdPuy7pvPKeVVFG1vV4RpdFKoK5uY0F-hzs_5YbeP9-9tu9byPNWW8i7kiXEMhCkUPnGicK6p0CkWqMGU6YUkCAnPNUqCYZ1SlmhPGIM-LIkkUxnSB7qfe1ruv3oRO1jZoU1WqMa4PkgwdmHHBxYCSCdXeheBNIYdfauW_JQY5ipOlHMXJUZycxA2hu1N_f6hN_hf5NTUAjxNghi-P1ngZtB2kmNx6ozuZO_tf_w825Hzy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2454156767</pqid></control><display><type>article</type><title>Haptic Evaluation of 3D-printed Braille-encoded Intraoral Films</title><source>ScienceDirect Freedom Collection</source><creator>Eleftheriadis, Georgios K. ; Fatouros, Dimitrios G.</creator><creatorcontrib>Eleftheriadis, Georgios K. ; Fatouros, Dimitrios G.</creatorcontrib><description>The three-dimensional (3D) printing technology has recently emerged in the pharmaceutical field, providing an array of applications for individualized dosing and elaborate formulation designs. However, an alternative asset of the 3D printing technology is the capability to imprint haptic identifiers directly onto the surface of the formulations. This approach can generate novel design concepts, that will serve specific populations for identifying the right treatment regimen, i.e., visually impaired people. Toward this direction, the fused deposition modelling (FDM) technique was investigated for manufacturing intraoral films and incorporating Braille characters on the available area. The films comprised a drug-loaded compartment and a backing layer, which are typical structural characteristics for buccal delivery. A hydrophilic polymer, i.e., hydroxypropyl methylcellulose, provided the polymer matrix for both compartments, whereas ketoprofen was incorporated in the study as model drug. The Braille-encoded texts were designed on top of the backing layer, complying with the Marburg Medium spacing convention for pharmaceutical Braille. Moreover, modifications on the standard spacing and dimension parameters were applied, to investigate the accuracy and repeatability of the FDM process. The fabricated films were subjected to a haptic evaluation study with the aid of visually impaired individuals, to assess the readability of the 3D-printed Braille-encoded text. The outcomes of the study highlighted the capacity of the FDM technology in combining novel manufacturing concepts for individualized therapies with customized services that can be provided to specific populations, as in the case of people with visual impairment. [Display omitted]</description><identifier>ISSN: 0928-0987</identifier><identifier>EISSN: 1879-0720</identifier><identifier>DOI: 10.1016/j.ejps.2020.105605</identifier><identifier>PMID: 33091570</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Additive manufacturing ; Braille ; Buccal films ; Fused deposition modeling ; Intraoral formulations ; Three-dimensional printing ; Visual impairment</subject><ispartof>European journal of pharmaceutical sciences, 2021-02, Vol.157, p.105605-105605, Article 105605</ispartof><rights>2020</rights><rights>Copyright © 2020. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-6a26c0f7fa3b62c1da3ac80f8a135c45440716c58031693a8c62550ddff44a113</citedby><cites>FETCH-LOGICAL-c356t-6a26c0f7fa3b62c1da3ac80f8a135c45440716c58031693a8c62550ddff44a113</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33091570$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Eleftheriadis, Georgios K.</creatorcontrib><creatorcontrib>Fatouros, Dimitrios G.</creatorcontrib><title>Haptic Evaluation of 3D-printed Braille-encoded Intraoral Films</title><title>European journal of pharmaceutical sciences</title><addtitle>Eur J Pharm Sci</addtitle><description>The three-dimensional (3D) printing technology has recently emerged in the pharmaceutical field, providing an array of applications for individualized dosing and elaborate formulation designs. However, an alternative asset of the 3D printing technology is the capability to imprint haptic identifiers directly onto the surface of the formulations. This approach can generate novel design concepts, that will serve specific populations for identifying the right treatment regimen, i.e., visually impaired people. Toward this direction, the fused deposition modelling (FDM) technique was investigated for manufacturing intraoral films and incorporating Braille characters on the available area. The films comprised a drug-loaded compartment and a backing layer, which are typical structural characteristics for buccal delivery. A hydrophilic polymer, i.e., hydroxypropyl methylcellulose, provided the polymer matrix for both compartments, whereas ketoprofen was incorporated in the study as model drug. The Braille-encoded texts were designed on top of the backing layer, complying with the Marburg Medium spacing convention for pharmaceutical Braille. Moreover, modifications on the standard spacing and dimension parameters were applied, to investigate the accuracy and repeatability of the FDM process. The fabricated films were subjected to a haptic evaluation study with the aid of visually impaired individuals, to assess the readability of the 3D-printed Braille-encoded text. The outcomes of the study highlighted the capacity of the FDM technology in combining novel manufacturing concepts for individualized therapies with customized services that can be provided to specific populations, as in the case of people with visual impairment. [Display omitted]</description><subject>Additive manufacturing</subject><subject>Braille</subject><subject>Buccal films</subject><subject>Fused deposition modeling</subject><subject>Intraoral formulations</subject><subject>Three-dimensional printing</subject><subject>Visual impairment</subject><issn>0928-0987</issn><issn>1879-0720</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kEFLwzAUx4Mobk6_gAfp0UvnS9IkLQiic3ODgRc9hyxNIaVtatIO_Pa2dHr09HiP3_8P74fQLYYlBswfyqUp27AkQMYD48DO0BynIotBEDhHc8hIGkOWihm6CqEEAJ4KuEQzSiHDTMAcPW1V21kdrY-q6lVnXRO5IqKvcett05k8evHKVpWJTaNdPuy7pvPKeVVFG1vV4RpdFKoK5uY0F-hzs_5YbeP9-9tu9byPNWW8i7kiXEMhCkUPnGicK6p0CkWqMGU6YUkCAnPNUqCYZ1SlmhPGIM-LIkkUxnSB7qfe1ruv3oRO1jZoU1WqMa4PkgwdmHHBxYCSCdXeheBNIYdfauW_JQY5ipOlHMXJUZycxA2hu1N_f6hN_hf5NTUAjxNghi-P1ngZtB2kmNx6ozuZO_tf_w825Hzy</recordid><startdate>20210201</startdate><enddate>20210201</enddate><creator>Eleftheriadis, Georgios K.</creator><creator>Fatouros, Dimitrios G.</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20210201</creationdate><title>Haptic Evaluation of 3D-printed Braille-encoded Intraoral Films</title><author>Eleftheriadis, Georgios K. ; Fatouros, Dimitrios G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-6a26c0f7fa3b62c1da3ac80f8a135c45440716c58031693a8c62550ddff44a113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Additive manufacturing</topic><topic>Braille</topic><topic>Buccal films</topic><topic>Fused deposition modeling</topic><topic>Intraoral formulations</topic><topic>Three-dimensional printing</topic><topic>Visual impairment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eleftheriadis, Georgios K.</creatorcontrib><creatorcontrib>Fatouros, Dimitrios G.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eleftheriadis, Georgios K.</au><au>Fatouros, Dimitrios G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Haptic Evaluation of 3D-printed Braille-encoded Intraoral Films</atitle><jtitle>European journal of pharmaceutical sciences</jtitle><addtitle>Eur J Pharm Sci</addtitle><date>2021-02-01</date><risdate>2021</risdate><volume>157</volume><spage>105605</spage><epage>105605</epage><pages>105605-105605</pages><artnum>105605</artnum><issn>0928-0987</issn><eissn>1879-0720</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>The three-dimensional (3D) printing technology has recently emerged in the pharmaceutical field, providing an array of applications for individualized dosing and elaborate formulation designs. However, an alternative asset of the 3D printing technology is the capability to imprint haptic identifiers directly onto the surface of the formulations. This approach can generate novel design concepts, that will serve specific populations for identifying the right treatment regimen, i.e., visually impaired people. Toward this direction, the fused deposition modelling (FDM) technique was investigated for manufacturing intraoral films and incorporating Braille characters on the available area. The films comprised a drug-loaded compartment and a backing layer, which are typical structural characteristics for buccal delivery. A hydrophilic polymer, i.e., hydroxypropyl methylcellulose, provided the polymer matrix for both compartments, whereas ketoprofen was incorporated in the study as model drug. The Braille-encoded texts were designed on top of the backing layer, complying with the Marburg Medium spacing convention for pharmaceutical Braille. Moreover, modifications on the standard spacing and dimension parameters were applied, to investigate the accuracy and repeatability of the FDM process. The fabricated films were subjected to a haptic evaluation study with the aid of visually impaired individuals, to assess the readability of the 3D-printed Braille-encoded text. The outcomes of the study highlighted the capacity of the FDM technology in combining novel manufacturing concepts for individualized therapies with customized services that can be provided to specific populations, as in the case of people with visual impairment. [Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>33091570</pmid><doi>10.1016/j.ejps.2020.105605</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0928-0987
ispartof European journal of pharmaceutical sciences, 2021-02, Vol.157, p.105605-105605, Article 105605
issn 0928-0987
1879-0720
language eng
recordid cdi_proquest_miscellaneous_2454156767
source ScienceDirect Freedom Collection
subjects Additive manufacturing
Braille
Buccal films
Fused deposition modeling
Intraoral formulations
Three-dimensional printing
Visual impairment
title Haptic Evaluation of 3D-printed Braille-encoded Intraoral Films
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T02%3A30%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Haptic%20Evaluation%20of%203D-printed%20Braille-encoded%20Intraoral%20Films&rft.jtitle=European%20journal%20of%20pharmaceutical%20sciences&rft.au=Eleftheriadis,%20Georgios%20K.&rft.date=2021-02-01&rft.volume=157&rft.spage=105605&rft.epage=105605&rft.pages=105605-105605&rft.artnum=105605&rft.issn=0928-0987&rft.eissn=1879-0720&rft_id=info:doi/10.1016/j.ejps.2020.105605&rft_dat=%3Cproquest_cross%3E2454156767%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-6a26c0f7fa3b62c1da3ac80f8a135c45440716c58031693a8c62550ddff44a113%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2454156767&rft_id=info:pmid/33091570&rfr_iscdi=true